companydata.dkcompanydata.dk

Wallentin Medical Consulting ApS: Financial statements 2024

CVR: 41746505

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Wallentin Medical Consulting ApS (CVR 41746505) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 676,331 and a net result of DKK 517,283 compared with DKK 498,557 the year before. That is an increase of 3.3% compared with the year before. Equity in the 2024 report amounted to DKK 1,292,337. The solvency ratio was 82.7%.

Gross Profit
DKK 676,331
Profit/Loss
DKK 517,283
Equity
DKK 1,292,337
Total Assets
DKK 1,562,141

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-676K517K1.3M-
2023-655K499K897K-
2022-622K468K516K-
2021-1.2M953K1.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Wallentin Medical Consulting ApS: The 2023 annual report is outJul 1, 2024

Wallentin Medical Consulting ApS has published its annual report for 2023. Gross profit came to DKK 654,578, and the net result was DKK 498,557.

About Wallentin Medical Consulting ApS

Wallentin Medical Consulting ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2020. The company is registered under the industry Alment praktiserende lægers aktiviteter. The management consists of Rikke Søjborg Wallentin. The company is owned by Rikke Søjborg Wallentin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 684,736 and a net result of DKK 527,610 compared with DKK 517,283 the year before. Equity in the 2025 report amounted to DKK 1,684,947.

Source: annual report 2025, Danish Business Authority

Other financial years